In a multi-stage application process, Nia Health was able to prevail over 50 other talented young companies from the biotech, medtech and digital health industry from Germany, Austria and Switzerland. Nia Health’s medical product (risc class I), the Eczema App Nia, also convinced the topclass jury in the final round of the pitch competition of the last 15 start-ups. The jury included John Butler, VP External Innovation at Bayer and Dr. Klaus Suwelack, New Venture Lead Germany at Johnson & Johnson.
The EIT Health Headstart Awards are part of EIT Health’s extensive portfolio of support programmes for emerging companies and SMEs from across Europe. The purpose of these awards is to accelerate market entry and adoption of new products and services, thus creating new economic activity.
You can find more information here: https://eit-health.de/
Nia Health GmbH
Altensteinstraße 40
14195 Berlin
Telefon: +49 (30) 50930415
http://www.nia-health.de/
Telefon: +49 (163) 7687124
E-Mail: tobias.seidl@nia-health.de
